| For: | Ishida K, Inoue T, Fujiwara K, Sakanaka T, Narabayashi K, Nouda S, Okada T, Kakimoto K, Kuramoto T, Kawakami K, Abe Y, Takeuchi T, Murano M, Tokioka S, Umegaki E, Higuchi K. Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn’s disease patients. World J Gastroenterol 2013; 19(17): 2676-2682 [PMID: 23674875 DOI: 10.3748/wjg.v19.i17.2676] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i17/2676.htm |
| Number | Citing Articles |
| 1 |
Justin Côté-Daigneault, Mickael Bouin, Raymond Lahaie, Jean-Frédéric Colombel, Pierre Poitras. Biologics in inflammatory bowel disease: what are the data?. United European Gastroenterology Journal 2015; 3(5) doi: 10.1177/2050640615590302
|
| 2 |
Bincy P. Abraham, Tasneem Ahmed, Tauseef Ali. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239 doi: 10.1007/164_2016_122
|
| 3 |
Jean M. Chalhoub, Hussein H. Rimmani, Vivek V. Gumaste, Ala I. Sharara. Systematic Review and Meta-analysis. Inflammatory Bowel Diseases 2017; 23(8) doi: 10.1097/MIB.0000000000001203
|
| 4 |
Xinlong Wang, Weihua Xu, Yushan Wu, Peifeng Liu, Bing Wang, Jianfeng Li, Huili Dai. Clinical combination therapy for IBD and promising co-delivery strategies. Inflammopharmacology 2026; 34(6) doi: 10.1007/s10787-026-02222-5
|
| 5 |
Edward L. Barnes, Alison Goldin, Rachel W. Winter, Emily Collins, Bonnie Cao, Madeline Carrellas, Anne Marie Crowell, Joshua R. Korzenik. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery. Digestive Diseases and Sciences 2016; 61(11) doi: 10.1007/s10620-016-4302-3
|
| 6 |
Chen-Wang Chang, Shu-Chen Wei, Jen-Wei Chou, Tzu-Chi Hsu, Chiao-Hsiung Chuang, Ching-Pin Lin, Wen-Hung Hsu, Hsu-Heng Yen, Jen-Kou Lin, Yi-Jen Fang, Horng-Yuan Wang, Hung-Hsin Lin, Deng Cheng Wu, Yen Hsuan Ni, Cheng-Yi Wang, Jau-Min Wong. Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study. Intestinal Research 2014; 12(4) doi: 10.5217/ir.2014.12.4.287
|
| 7 |
Fuminao Takeshima, Daisuke Yoshikawa, Syuntaro Higashi, Tomohito Morisaki, Hidetoshi Oda, Maho Ikeda, Haruhisa Machida, Kayoko Matsushima, Hitomi Minami, Yuko Akazawa, Naoyuki Yamaguchi, Ken Ohnita, Hajime Isomoto, Masato Ueno, Kazuhiko Nakao. Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0501-9
|
| 8 |
Hyungil Seo, Byong Duk Ye, Eun Mi Song, Sun-Ho Lee, Kiju Chang, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang. Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea. Digestive Diseases and Sciences 2017; 62(10) doi: 10.1007/s10620-017-4715-7
|
| 9 |
Takayuki Matsumoto, Satoshi Motoya, Kenji Watanabe, Tadakazu Hisamatsu, Hiroshi Nakase, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, Masakazu Nagahori, Toshiyuki Matsui, Yuji Naito, Takanori Kanai, Yasuo Suzuki, Masanori Nojima, Mamoru Watanabe, Toshifumi Hibi. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial. Journal of Crohn's and Colitis 2016; 10(11) doi: 10.1093/ecco-jcc/jjw152
|
| 10 |
Yutaka Nagata, Motohiro Esaki, Junji Umeno, Yuta Fuyuno, Koji Ikegami, Yuji Maehata, Kouichi Asano, Tomohiko Moriyama, Shotaro Nakamura, Takanari Kitazono, Takayuki Matsumoto. Therapeutic Strategy for Crohn's Disease with a Loss of Response to Infliximab: A Single-Center Retrospective Study. Digestion 2015; 91(1) doi: 10.1159/000368815
|
| 11 |
Kaori Fujiwara, Takuya Inoue, Naoki Yorifuji, Munetaka Iguchi, Taisuke Sakanaka, Ken Narabayashi, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Yosuke Abe, Toshihisa Takeuchi, Kazuhide Higuchi. Effect of Adalimumab on an Enterocutaneous Fistula in Patients with Crohn's Disease: A Case Series. Internal Medicine 2015; 54(20) doi: 10.2169/internalmedicine.54.5405
|